Mutual of America Capital Management LLC trimmed its holdings in Cognex Co. (NASDAQ:CGNX – Free Report) by 4.2% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 98,285 shares of the scientific and technical instruments company’s stock after selling 4,279 shares during the quarter. Mutual of America Capital Management LLC owned about 0.06% of Cognex worth $4,596,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds have also bought and sold shares of the business. Vanguard Group Inc. increased its holdings in shares of Cognex by 1.1% during the first quarter. Vanguard Group Inc. now owns 17,522,549 shares of the scientific and technical instruments company’s stock valued at $743,307,000 after acquiring an additional 188,485 shares in the last quarter. Brown Capital Management LLC grew its position in Cognex by 5.1% during the 4th quarter. Brown Capital Management LLC now owns 5,419,313 shares of the scientific and technical instruments company’s stock valued at $226,202,000 after purchasing an additional 262,003 shares during the last quarter. Impax Asset Management Group plc increased its stake in Cognex by 32.8% during the 2nd quarter. Impax Asset Management Group plc now owns 5,098,711 shares of the scientific and technical instruments company’s stock valued at $237,812,000 after purchasing an additional 1,259,116 shares in the last quarter. William Blair Investment Management LLC raised its holdings in Cognex by 8.1% in the second quarter. William Blair Investment Management LLC now owns 4,018,539 shares of the scientific and technical instruments company’s stock worth $187,907,000 after buying an additional 301,916 shares during the last quarter. Finally, Nordea Investment Management AB raised its holdings in Cognex by 29.0% in the first quarter. Nordea Investment Management AB now owns 2,663,900 shares of the scientific and technical instruments company’s stock worth $113,722,000 after buying an additional 598,207 shares during the last quarter. Institutional investors own 88.12% of the company’s stock.
Insider Transactions at Cognex
In related news, Director Dianne M. Parrotte bought 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 7th. The stock was bought at an average cost of $38.62 per share, with a total value of $77,240.00. Following the completion of the purchase, the director now owns 11,340 shares of the company’s stock, valued at approximately $437,950.80. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, Director Dianne M. Parrotte purchased 2,000 shares of the business’s stock in a transaction on Wednesday, August 7th. The stock was acquired at an average price of $38.62 per share, for a total transaction of $77,240.00. Following the acquisition, the director now directly owns 11,340 shares of the company’s stock, valued at approximately $437,950.80. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Dennis Fehr acquired 6,570 shares of the firm’s stock in a transaction dated Wednesday, September 4th. The shares were purchased at an average cost of $38.04 per share, for a total transaction of $249,922.80. Following the completion of the acquisition, the chief financial officer now directly owns 6,570 shares in the company, valued at $249,922.80. The disclosure for this purchase can be found here. Insiders own 1.10% of the company’s stock.
Wall Street Analysts Forecast Growth
Get Our Latest Analysis on CGNX
Cognex Stock Performance
CGNX opened at $39.74 on Friday. Cognex Co. has a fifty-two week low of $34.28 and a fifty-two week high of $53.13. The stock has a market cap of $6.82 billion, a price-to-earnings ratio of 68.52 and a beta of 1.41. The firm’s fifty day moving average is $41.86 and its 200 day moving average is $43.24.
Cognex (NASDAQ:CGNX – Get Free Report) last released its quarterly earnings data on Wednesday, July 31st. The scientific and technical instruments company reported $0.17 earnings per share for the quarter, topping analysts’ consensus estimates of $0.14 by $0.03. The firm had revenue of $239.00 million during the quarter, compared to analyst estimates of $240.33 million. Cognex had a return on equity of 4.97% and a net margin of 9.29%. The business’s quarterly revenue was down 1.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.32 earnings per share. On average, equities research analysts predict that Cognex Co. will post 0.44 earnings per share for the current year.
Cognex Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 29th. Stockholders of record on Thursday, August 15th were given a dividend of $0.075 per share. This represents a $0.30 annualized dividend and a dividend yield of 0.75%. The ex-dividend date was Thursday, August 15th. Cognex’s payout ratio is currently 51.72%.
Cognex Company Profile
Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.
Read More
- Five stocks we like better than Cognex
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- MarketBeat Week in Review – 9/16 – 9/20
- How to Invest in Blue Chip Stocks
- Don’t Miss These 3 Retail Stocks for Fall Gains
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.